Chronic kidney disease, survival and graft-versus-host-disease-free/relapse-free survival in recipients of allogeneic hematopoietic stem cell transplant

BACKGROUND: Advances in allogeneic hematopoietic stem cell transplant (HSCT) have increased patient survival, although substantial treatment-related toxicity remains, including chronic kidney disease (CKD). We assessed the association between CKD and survival and transplant-specific outcomes in HSCT...

Descripción completa

Detalles Bibliográficos
Autores principales: Pelletier, Karyne, Côté, Gabrielle, Madsen, Kayla, Chen, Shiyi, Kim, S Joseph, Chan, Christopher T, Mattsson, Jonas, Pasic, Ivan, Kitchlu, Abhijat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9308100/
https://www.ncbi.nlm.nih.gov/pubmed/35892015
http://dx.doi.org/10.1093/ckj/sfac091

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9308100/
https://www.ncbi.nlm.nih.gov/pubmed/35892015
http://dx.doi.org/10.1093/ckj/sfac091

Ejemplares similares